You are here

Theresa Ahrens

Theresa Ahrens

Institution: University Freiburg Medical Centre
Department: Institute of Pathology
E-mail: theresa.ahrens@uniklinik-freiburg.de
Phone: +49-(0)761-270 80300
Homepage: Silke Laßmann

2006 - 2011 Study of Molecular Medicine, Albert-Ludwigs-University of Freiburg
2011 Diploma thesis in Molecular Medicine, Albert-Ludwigs-University of Freiburg
2011 - 2012 PhD student in the lab of Dr. Meike Burger, Department of Haematology and Oncology, University Freiburg Medical Centre
2012 - present PhD student in the lab of Prof. Dr. Silke Laßmann, Institute of Pathology, University Freiburg Medical Centre
2015 PhD thesis, Albert-Ludwigs-University of Freiburg

Publications

  • Ahrens T.D., Timme S., Ostendorp J., Bogatyreva L., Hoeppner J., Hopt U.T., Hauschke D., Werner M. and Lassmann S. (2016) Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity. Lab Invest 96, 307-316.
  • Ahrens T.D., Werner M. and Lassmann S. (2014) Epigenetics in esophageal cancers. Cell Tissue Res 356, 643-655
  • Krohn A*, Ahrens T*, Yalcin A, Plones T, Wehrle J, Taromi S, et al. Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes. PloS one. 2014;9(6):e100249. PubMed PMID: 24959847. * authors contributed equally to this work
  • Tholen S, Biniossek ML, Gansz M, Ahrens TD, Schlimpert M, Kizhakkedathu JN, et al. Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis. Cellular and molecular life sciences : CMLS. 2014 Mar;71(5):899-916. PubMed PMID: 23811845.
  • Ahrens TD, Timme S, Hoeppner J, Ostendorp J, Hembach S, Follo M, Hopt UT, Werner M, Busch H, Boerries M and Lassmann S. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. Epigenetics. 2015;10(5):431-445.